Related references
Note: Only part of the references are listed.An Impedance-Based Cellular Assay Using Human iPSC-Derived Cardiomyocytes to Quantify Modulators of Cardiac Contractility
Clay W. Scott et al.
TOXICOLOGICAL SCIENCES (2014)
High-Throughput Multi-Parameter Profiling of Electrophysiological Drug Effects in Human Embryonic Stem Cell Derived Cardiomyocytes Using Multi-Electrode Arrays
Mike Clements et al.
TOXICOLOGICAL SCIENCES (2014)
Screening Drug-Induced Arrhythmia Events Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Low-Impedance Microelectrode Arrays
Enrique G. Navarrete et al.
CIRCULATION (2013)
In vitro Model for Assessing Arrhythmogenic Properties of Drugs Based on High-resolution Impedance Measurements
Filomain Nguemo et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review
Carl-Fredrik Mandenius et al.
JOURNAL OF APPLIED TOXICOLOGY (2011)
Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure
Mihaela Gherghiceanu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Modelling the long QT syndrome with induced pluripotent stem cells
Ilanit Itzhaki et al.
NATURE (2011)
Functional Cardiotoxicity Profiling and Screening Using the xCELLigence RTCA Cardio System
Biao Xi et al.
JALA (2011)
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome.
Alessandra Moretti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes
Malin K. B. Jonsson et al.
STEM CELL RESEARCH (2010)
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Stefan R. Braam et al.
STEM CELL RESEARCH (2010)
In Vitro Electrophysiological Drug Testing Using Human Embryonic Stem Cell Derived Cardiomyocytes
Oren Caspi et al.
STEM CELLS AND DEVELOPMENT (2009)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Drug-induced long QT and torsade de pointes: recent advances
Prince J. Kannankeril et al.
CURRENT OPINION IN CARDIOLOGY (2007)
Effect of haloperidol on transient outward potassium current in rat ventricular myocytes
Marketa Bebarova et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Inhibition of ATP-sensitive potassium channels by haloperidol
SB Yang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
The impact of drug-induced qt interval prolongation on drug discovery and development
B Fermini et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential
Y Satoh et al.
JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION (2000)
Share Paper
